Xarelto (rivaroxoaban), jointly marketed by Bayer and Johnson & Johnson, is almost chemically identical to another blood thinner and rival product, Pradaxa.  These drugs have adverse side effects and can cause serious harm. Denver mass tort lawyers Andrus Wagstaff are investigating potential lawsuits on behalf of patients harmed by Xarelto, and lawsuits have already been filed.

Is Xarelto the Next Pradaxa?

Xarelto (rivaroxoaban), jointly marketed by Bayer and Johnson & Johnson, is almost chemically identical to another blood thinner and rival product, Pradaxa. In May Boehringer Ingelheim, maker of Pradaxa, paid $650 million to settle approximately 4,000 lawsuits filed by patients who claimed that Boehringer failed to warn them about the drug’s ability to cause serious, irreversible, and sometimes fatal bleeding.

Continue reading
1253 Hits
0 Comments

Media Contact

Selena Saucedo
Marketing Manager
720-208-9405
selena.saucedo@andruswagstaff.com

Contact our firm

<a href="https://secure.blueoctane.net/forms/WYEV0LCXOM8K">Click Here To Load This Formexperts.com Form</a>

National Mass Tort Attorneys
Headquartered in Denver
Toll Free: 866-795-9529